← Back to Search

Whole-Body MRI for Metastatic Cancer

N/A

Waitlist Available

Led By Marilyn J. Siegel, MD

Research Sponsored by American College of Radiology Imaging Network

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 21 and under

Confirmed diagnosis OR newly diagnosed mass strongly suspected to represent Rhabdomyosarcoma, Ewing's sarcoma family of tumors, Neuroblastoma, Hodgkin's lymphoma, or Non-Hodgkin's lymphoma

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is testing whether using whole-body MRI to detect metastatic cancer is better than standard imaging procedures.

Who is the study for?

This trial is for young patients (21 or under) with solid tumors or lymphoma, such as Rhabdomyosarcoma, Ewing's sarcoma, Neuroblastoma, Hodgkin's and Non-Hodgkin's lymphoma. They must not be pregnant or nursing and should have no MRI contraindications like metal implants. Diabetic patients can join if their condition is controlled.Check my eligibility

What is being tested?

The study compares whole-body MRI to standard imaging methods like CT scans in finding cancer spread in the body. It aims to see if whole-body MRI gives better information about how far the disease has spread before starting treatment.See study design

What are the potential side effects?

Since this trial involves imaging techniques rather than drugs, there are no direct side effects from medications. However, some may experience discomfort during an MRI scan due to its duration or claustrophobia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 years old or younger.

Select...

I have or am suspected to have a specific type of cancer like Rhabdomyosarcoma or Lymphoma.

Select...

My diabetes is under control.

Select...

My diabetes is under control with a fasting blood sugar not over 200 mg/dL.

Select...

I have had a whole body MRI and PET scan before starting treatment.

Select...

I have never had cancer before.

Select...

My cancer did not start in my brain or spinal cord.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 7Eligibility criteria met

Find a Location

Who is running the clinical trial?

American College of Radiology Imaging NetworkLead Sponsor

39 Previous Clinical Trials

466,649 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,932,927 Total Patients Enrolled

453 Trials studying Sarcoma

229,873 Patients Enrolled for Sarcoma

Marilyn J. Siegel, MDPrincipal InvestigatorMallinckrodt Institute of Radiology at Washington University Medical Center

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00072488 — N/A

Sarcoma Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00072488 — N/A

Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00072488 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you inform me of the number of medical sites currently administering this clinical trial in city?

"The clinical trial is presently occurring at 21 sites, ranging from Miami and Halifax to Iowa City. To minimise travelling costs, it may be beneficial for patients to select a nearby site that encompasses their participation."

Answered by AI

Is this research currently enrolling participants?

"Per the information on clinicaltrials.gov, patient recruitment for this medical trial has concluded as of June 5th 2010. Initially posted in 2004, it is no longer actively seeking candidates; however, there are currently 2,257 other studies actively recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma

2004. "Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00072488.

All > Bone Metastases > Neuroblastoma